openPR Logo
Press release

Octreotide Market Expected to Grow Faster According to New Research Report – 2026

02-07-2019 06:33 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Octreotide Market Expected to Grow Faster According to New

Octreotide are amino acid monomer which is attached to amide group. The octreotide acts similar to the hormone somatostatin. Octreotide basically lowers the variety of hormone such as insulin, glucagon, growth hormone and others, Octreotide reduces chemical messengers such as gastrin, vasoactive intestinal peptide that cause disease symptoms. Octreotide depending upon the severity generally severe diarrhea, acromegaly as well as for treating flushing in patients with tumors. Octreotride is also used to reduction of the side effects from cancer chemotherapy. The global Octreotide market was estimated to be around U.S $ 1.6 Bn. in 2013 .The estimated CAGR for Octreotide market from 2012 to 2013 was approximately 5%. The use of octreotide is expected to grow because of increase in number of people diagnosed with cancer, diarrhea and tumors.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1266

Octreotide Market: Drivers and Restraints

The global demand for octreotide is driven by growing number of people under the diagnosis of cancer. In 2012, there were estimated 14.1 million cases of cancer .It is estimated that by 2035, the number of people suffering from cancer will be around 24 million. These estimate shows that the demand for treatment drugs such as octreotide will grow. It is forecasted that around 2200 children die every day due to severe diarrhea, more than Aids, malaria and measles combined. Henceforth it is important to tackle these world challenges by supplying adequate octreotide drugs for the diseased. The use of octreotide in radiolabelling will substantially increase the demand for Octreotide.

The increasing popularity of generic drugs might affect the consumption of branded drugs. The availability of generic drugs is expected to grow because of cost factor and hence will affect the overall Pharmaceutical industry if not restructured according to the market and consumer needs. The important restraining factor for Octreotide Market is the lack research of Octreotide for the treatment of children, pregnant and lactating women. The use of Octreotide is based on risk factor analysis hence might affect the consumption of Octreotide.

Octreotide Market: Segmentation

On the basis of Type, global Octreotide Market is segmented into:

octreotide acetate

octreotide

octreotide chloride

octreotide hydrochloride

indium In-111; octreotide

On the basis of End use, global Octreotide Market is segmented into:

Pharmaceutical

Clinical Research

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/toc/rep-gb-1266

Octreotide Market: Key market Players

Some of the Octreotide producers are Novartis pharmaceuticals corp., App pharmaceuticals llc, Bedford laboratories div ben venue laboratories Inc., Sun pharmaceutical industries ltd., Sinopharm A-THINK Pharmaceutical Co., Ltd., Teva parenteral medicines Inc., Neiss Labs Pvt. Ltd., Samarth Pharma Pvt. Ltd. J.B. Chemicals and Pharmaceuticals Ltd and others

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Octreotide Market Expected to Grow Faster According to New Research Report – 2026 here

News-ID: 1567172 • Views:

More Releases from Future Market Insights

Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Advanced Technology Integration
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels. As e-commerce continues to penetrate global
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Technological Innovation
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications. The expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Security Infrastructure Expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across
UK Cosmetic Tubes Market Set for 6.53% Growth Amid Rising Demand for Skincare Innovation
UK Cosmetic Tubes Market Set for 6.53% Growth Amid Rising Demand for Skincare In …
The global cosmetic tubes market is on a trajectory of remarkable growth, projected to expand from USD 2.9 billion in 2025 to USD 4.6 billion by 2035, representing a steady CAGR of 4.7%. As a key segment of the broader USD 35.8 billion cosmetic packaging industry, tubes account for an 8.1% share of total packaging demand by value. Rising consumer interest in skincare, personal grooming, and travel-friendly formats is fueling

All 5 Releases


More Releases for Octreotide

Octreotide Acetate Market | Exploring Current Trends and Growth Status for 2025
Octreotide Acetate Market Outlook and Investment Analysis What is the outlook for the Octreotide Acetate market in the coming years? The Octreotide Acetate market is anticipated to experience steady growth due to its increasing applications in the treatment of various conditions, such as neuroendocrine tumors, acromegaly, and gastrointestinal disorders. Factors like a growing geriatric population, rising incidences of these disorders, and advancements in drug formulations are expected to fuel the demand for
Octreotide Acetate Market is Rising in Upcoming Years | 2024-2031
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Octreotide Acetate Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in
Octreotide Acetate Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Octreotide Acetate Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The octreotide acetate market is witnessing steady growth due to its critical role in the treatment of various medical conditions such as acromegaly, neuroendocrine tumors,
Octreotide Market to 2030: Ongoing research and development efforts aimed at imp …
Octreotide is a medication used in the treatment of various medical conditions such as acromegaly, carcinoid syndrome, and diarrhea. It is a synthetic analogue of the naturally occurring hormone somatostatin and acts by suppressing the release of certain hormones and neurotransmitters in the body. The octreotide market is a growing market, with increasing demand for the drug in the treatment of various medical conditions. Major pharmaceutical companies are involved in
Global Octreotide Market 2019 - Novartis, Sun Pharmaceutical, Chengdu Tiantaisha …
This new report by Eon Market Research, titled “Global Octreotide Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Octreotide industry at a global as well as regional and country level. Key facts analyzed in this report include the Octreotide market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Octreotide Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Octreotide market. Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid. The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach